Acasti Pharma Inc. | Balance Sheet
Fiscal year is April-March. All values CAD Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
23,701.40
18,381.90
10,470.10
9,772.00
8,223.00
34,386
Total Accounts Receivable
1,150.30
854.50
398.80
206.00
759.00
1,586
Inventories
261.40
87.40
-
-
-
-
Other Current Assets
703.50
318.50
456.50
209.00
510.00
1,180
Total Current Assets
25,816.70
19,642.30
11,325.40
10,187.00
9,492.00
37,152
Net Property, Plant & Equipment
38.90
69.90
287.10
2,881.00
2,821.00
2,813
Total Investments and Advances
-
-
2,000.00
-
26.00
27
Intangible Assets
19,776.20
17,495.90
14,904.80
12,388.00
10,065.00
7,743
Other Assets
-
-
-
-
555.00
736
Total Assets
45,631.80
37,208.10
28,517.30
25,456.00
22,959.00
48,471
Accounts Payable
319.70
246.50
375.20
-
3,420.00
Other Current Liabilities
851.10
1,375.90
765.70
2,138.00
3,277.00
Total Current Liabilities
1,170.80
1,622.40
1,140.90
2,138.00
6,697.00
Long-Term Debt
-
-
-
1,406.00
1,612.00
Other Liabilities
11,181.50
2,357.40
156.40
209.00
6,426.00
Total Liabilities
12,352.30
3,979.80
1,297.30
3,753.00
14,735.00
Common Equity (Total)
33,279.50
33,228.30
27,220.00
21,703.00
8,224.00
Total Shareholders' Equity
33,279.50
33,228.30
27,220.00
21,703.00
8,224.00
Total Equity
33,279.50
33,228.30
27,220.00
21,703.00
8,224.00
Liabilities & Shareholders' Equity
45,631.80
37,208.10
28,517.30
25,456.00
22,959.00
About Acasti Pharma
View Profile
